Abstract

OPTIMIZATION OF VITAMIN C THERAPY FOR PREVENTION AND MANAGEMENT OF RESPIRATORY INFECTIONS

Dr. Asif Rasheed*, Maryam Sadiq, Khuba Raniya, Mohammed Akram Rayan Ahmed, Mohammed Abdul Mughani

.

Abstract

Vitamin C, is a crucial water-soluble nutrient. In order to maintain a normal plasma level of 50 mol/L, which is the mean plasma level in UK adults, the EU Average Requirement is 90 mg/day for males and 80 mg/day for women. This can be insufficient when a person is exposed to a virus and is experiencing physiological stress, but it is sufficient to prevent scurvy. Everyone should take 200 mg of a supplement, according to a recommendation made by an expert panel working with the Swiss Society of Nutrition, "to address the nutrient gap for the general population and notably for the people age 65 and above." The purpose of this supplement is to boost the immune system. Vitamin C contains strong anti-oxidant and anti-inflammatory properties that lower the risk of tissue damage caused by oxidative stress and diminish the cytokine storm, an overactive inflammatory response. By boosting interferon synthesis and promoting lymphocyte proliferation, vitamin C enhances the host's defence against viral infection. It has been demonstrated that vitamin C can help prevent other respiratory infections like influenza, cold, pneumonia, ARDS, and treat some severe COVID-19 and also anti-microbial effects.

Keywords: Vitamin c, deficiency, influenza, cold, pneumonia, COVID19, antimicrobials, sepsis.